On September 8th 2012 six Principal Investigators (PIs) from UCL met with six PIs from Yale University for a one-day meeting on Imaging & Sensing in New Haven. They were chosen based on an open call to both institutions aimed at finding and supporting up to two Flagship Projects in this area as part of the Yale-UCL Medical Technologies Collaborative (MTC). Areas covered in this first workshop included liposomal reporting, contrast agents, implant coatings, MRI-informed surgery and blood flow measurements to name a few.
The second workshop in Biomaterials & Drug Delivery was held over the weekend of the 3rd-4th November 2012 in London with the third workshop in Vascular Engineering in New Haven on 8th December 2012. Following numerous applications two Flagship projects from each workshop have been selected. The projects are designed to be entirely new, entirely co-owned projects. As a transatlantic partnership, collaborators can be ‘home team’ players on both sides, accessing preclinical facilities in the US, and able to run clinical trials in the UK and when it comes to follow-on funding, able to access public and private funds in the UK, EU and US.
For each Flagship Project the IBME is offering exchange bursaries to enable PhD students and postdocs from UCL to work in Yale for up to three months to work on the proof of concept phase of the project covering travel costs and living allowance. A second ‘Market Validation’ workshop then follows where Flagship Project PIs from Yale & UCL will attend, along with relevant third parties such as product development, user group management, regulatory, and reimbursement experts.